	Ruben Dagda Pittsburgh Medical Technology Examiner \| Bio My Bio Subscribe RSS Feed Favorites

Find out more about Ruben:

Ruben Dagda, Ph.D. has authored multiple research manuscripts and review articles in the areas of toxicology and neurobiology. As a research associate and an educator at the University of Pittsburgh, he is interested in enhancing public awareness on the benefits of biomedical research in improving the quality of life, and understanding brain-related diseases. He has presented his research at national conferences and has received numerous awards for his contributions to Parkinson's disease.

Subscribe to Ruben's Email Alerts

Get alerts when Ruben submits a new article

Ruben has been added to your favorite examiners

View my favorite Examiners

Pittsburgh Medical Technology Examiner's Articles

Showing: Novel therapies articles

Coloring and lighting up the brain: new techniques allow investigators to map the human brain

The inception of the Golg stain in 1887 literally revolutionized the field of neurobiology. This staining technique was further refined and improved...
Keep Reading »

Researchers develop new techniques to enhance spinal cord regeneration after injury

1 comment

New discoveries in spinal cord regeneration research were unveiled by a superb panel of well known spinal cord investigators during a press conference...
Keep Reading »

Exercise delays neuronal death and improves quality of life in Parkinson's disease animal models.

Groundbreaking research performed in rhesus macaque monkeys and in rodents showed the benefits of exercise in a neurotoxin model of Parkinson’s...
Keep Reading »

From medical uses to cosmetic additive: how nano-diamonds may improve the quality of life

Nanotechnology seems to be pushing the envelope further and further as new applications are unveiled every year. As mentioned and summarized in other...
Keep Reading »

Promising new clinical trials will test whether antioxidants slow progression of Parkinson's disease

More hope is on the way for Parkinson's disease (PD) patients. A large multi-scale Phase III clinical trial study will be conducted by many academic...
Keep Reading »

Tissue engineering 101: how stem cells grown in scaffolds hold the key to curing osteoarthritis

Great strides in tissue engineering and stem cell research have further pushed the envelope further this year towards finding a cure to osteoarthritis...
Keep Reading »

Society for neuroscience 2009: a panoply of potential cures for neurodegenerative diseases

1 comment

Every year, about 30,000-40,000 neuroscientists from all over the world come to the United States to showcase their work-in-progress in the field of...
Keep Reading »

Fatostatin, a new weight lowering drug, turns off fat genes in mice; a promising therapy for obesity

Over the last decade, there has been a trend towards an increase in the number and percentage of Americans in the US population that are classified as...
Keep Reading »

Eli Lilly pulls the plug on arzoxifene, a promising anti-osteoporosis and anti-breast cancer drug.

4 comments

In a major but unanticipated move by the pharmaceutical company Eli Lilly, the Indiana based company just decided to pull the promising...
Keep Reading »

Advances in aging research: why methionine restriction is an attractive life-extension strategy

Thus far, caloric restriction may be the most robust and convincing anti-aging intervention known so far, at least as observed in multiple animal...
Keep Reading »